ASI DATAMYTE Presents the Product of the Year 2016
ASI DATAMYTE, the global standard in enterprise quality management solutions, today announced the Product of the Year 2016 – QDA Non-Conformance Management. The proven module of ASI DATAMYTE’s CAQ Software QDA provides far more than only capturing non-conformities.
“A lot of our customers underestimate the application of our Non-Conformance Management Solution”, said Sven Tetzlaff, Product Manager of ASI DATAMYTE. “It is not only for identifying non conformities but you can use it also for your order management or action management.”
Simply declaring that a broken device has been reworked doesn’t bode well during an audit. Many firms have complaints that evolve into non-conformances because they fail to analyze, follow through and get to the root cause. They also get into trouble because there is no tie-in to a corrective and preventive action or management review – there is no integration.
ASI DATAMYTE’s Non-Conformance Management Solution keeps complaints under control with automated workflows and integrated data from other relevant areas. It pulls in ISO standards and FDA mandates, ties in CIP and CAPAs and rolls the consolidated and analyzed findings into intuitive focused report and decisive actions.
About ASI DATAMYTE
ASI DATAMYTE Inc. provides integrated software, hardware and services for driving best-in-class quality in manufacturing. Refining its solutions for more than 40 years, ASI DATAMYTE is serving the largest, most prestigious manufacturers with localized solutions on a global basis. ASI DATAMYTE is headquartered in Plymouth, MN, with offices and support centers in more than 40 countries.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
VERTEX-PHARMACEUTICALS19.10.2018 13:56 | pressemeddelelse
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene
TX-SCHLUMBERGER-LIMITED19.10.2018 13:02 | pressemeddelelse
Schlumberger Announces Third-Quarter 2018 Results
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum